Praj Q1 FY27: PAT +117% YoY (~25% ex one-off), still misses Street's ₹50-80 Cr bar
Praj Industries' consolidated Q1 FY27 revenue came in at ₹715.82 Cr, up 11.8% YoY but down 15.2% QoQ from a heavier Q4 FY26 execution base (₹844.56 Cr). Consolidated PAT of ₹11.61 Cr looks like it more than doubled YoY (+117% from ₹5.34 Cr), but roughly ₹8.90 Cr of the pre-tax gain came from a one-off insurance claim (fire-loss settlement at the Urwade plant, recognised in Other Income this quarter after final insurer approval — the underlying loss was already expensed in FY26). Stripping that out, adjusted consolidated PAT is closer to ₹6.7 Cr, putting adjusted YoY growth at roughly +25% — real, but far more modest than the reported headline. Against our pre-result preview, which flagged Street expectations of ₹750-850 Cr revenue, 5-7% EBITDA margin and ₹50-80 Cr PAT, the quarter is a clear miss on profitability: revenue landed near the low end of the range, EBITDA margin came in around 4.2%, and PAT — even on a reported basis — fell well short of the ₹50-80 Cr bar the Street had set.
Margins improved sequentially but not YoY: consolidated NPM rose to 1.58% from 1.34% in Q4 FY26 and 0.82% a year ago, while EBITDA margin (~4.2%) recovered from Q4's 3.71% but remains below the 4.91% posted in Q1 FY26 — consistent with the near-term margin headwinds management flagged on the last call. The quarter's revenue mix explains much of the pressure: domestic revenue rose 41% YoY to ₹538.6 Cr, but overseas revenue fell 31% YoY to ₹177.2 Cr, corroborating the tariff-driven order delays our preview called out as the key swing factor for FY27.
Standalone tells a steadier story: PAT of ₹25.44 Cr was up 27.5% YoY (from ₹19.96 Cr), much closer to the adjusted consolidated growth rate than the raw consolidated headline — the outsized consolidated swing stems largely from a very low year-ago subsidiary base rather than a step-change in the core engineering business. No exceptional items were booked this quarter (Q4 FY26 had carried a ₹8.06 Cr exceptional gain from a labour-code provision reversal), so this quarter's numbers are cleaner on that front even with the insurance-claim distortion in other income. Management's prior guidance — improved FY27 performance on bioenergy/advanced-manufacturing strength, a return to normal order intake, and Praj GenX moving toward break-even — is only partially verifiable here: the company reports a single operating segment, so GenX's standalone economics aren't disclosed, but the $52M Praj GenX data-center deal announced August 3 and the sequential margin recovery are both directionally consistent with that narrative. No standalone management press release or MD&A commentary was available in our records to cross-check against the numbers.
The board also approved the AGM and a ₹3.60 final dividend around this result, both administrative rather than numbers-moving. Going into Q2, the read is: organic growth continues at a moderate pace, but the quarter needed a one-off to clear even a modest profit bar, and it still missed the Street's more optimistic pre-result range — putting the onus on export order recovery and GenX traction to close the gap in H2 as management has guided.
